196 related articles for article (PubMed ID: 31628112)
1. Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy.
Szabo R; Callies LK; Bugge TH
Development; 2019 Nov; 146(22):. PubMed ID: 31628112
[TBL] [Abstract][Full Text] [Related]
2. Loss of HAI-2 in mice with decreased prostasin activity leads to an early-onset intestinal failure resembling congenital tufting enteropathy.
Szabo R; Bugge TH
PLoS One; 2018; 13(4):e0194660. PubMed ID: 29617460
[TBL] [Abstract][Full Text] [Related]
3. Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM.
Szabo R; Kawaguchi M; Kataoka H; Bugge TH
Development; 2023 Sep; 150(17):. PubMed ID: 37539662
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of EpCam mutation in mice and men.
Mueller JL; McGeough MD; Peña CA; Sivagnanam M
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G278-88. PubMed ID: 24337010
[TBL] [Abstract][Full Text] [Related]
5. Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.
Wu CJ; Feng X; Lu M; Morimura S; Udey MC
J Clin Invest; 2017 Feb; 127(2):623-634. PubMed ID: 28094766
[TBL] [Abstract][Full Text] [Related]
6. Enteroids expressing a disease-associated mutant of EpCAM are a model for congenital tufting enteropathy.
Das B; Okamoto K; Rabalais J; Kozan PA; Marchelletta RR; McGeough MD; Durali N; Go M; Barrett KE; Das S; Sivagnanam M
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G580-G591. PubMed ID: 31433211
[TBL] [Abstract][Full Text] [Related]
7. mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.
Guerra E; Lattanzio R; La Sorda R; Dini F; Tiboni GM; Piantelli M; Alberti S
PLoS One; 2012; 7(11):e49302. PubMed ID: 23209569
[TBL] [Abstract][Full Text] [Related]
8. Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
Salomon J; Goulet O; Canioni D; Brousse N; Lemale J; Tounian P; Coulomb A; Marinier E; Hugot JP; Ruemmele F; Dufier JL; Roche O; Bodemer C; Colomb V; Talbotec C; Lacaille F; Campeotto F; Cerf-Bensussan N; Janecke AR; Mueller T; Koletzko S; Bonnefont JP; Lyonnet S; Munnich A; Poirier F; Smahi A
Hum Genet; 2014 Mar; 133(3):299-310. PubMed ID: 24142340
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of Italian patients with congenital tufting enteropathy.
d'Apolito M; Pisanelli D; Faletra F; Giardino I; Gigante M; Pettoello-Mantovani M; Goulet O; Gasparini P; Campanozzi A
World J Pediatr; 2016 May; 12(2):219-24. PubMed ID: 26684320
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine.
Kawaguchi M; Yamamoto K; Takeda N; Fukushima T; Yamashita F; Sato K; Kitamura K; Hippo Y; Janetka JW; Kataoka H
Commun Biol; 2019; 2():11. PubMed ID: 30623107
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Epithelial Differentiation Contributes to Pathogenesis in a Murine Model of Congenital Tufting Enteropathy.
Das B; Okamoto K; Rabalais J; Young JA; Barrett KE; Sivagnanam M
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1353-1371. PubMed ID: 34198013
[TBL] [Abstract][Full Text] [Related]
12. EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.
Pathak SJ; Mueller JL; Okamoto K; Das B; Hertecant J; Greenhalgh L; Cole T; Pinsk V; Yerushalmi B; Gurkan OE; Yourshaw M; Hernandez E; Oesterreicher S; Naik S; Sanderson IR; Axelsson I; Agardh D; Boland CR; Martin MG; Putnam CD; Sivagnanam M
Hum Mutat; 2019 Feb; 40(2):142-161. PubMed ID: 30461124
[TBL] [Abstract][Full Text] [Related]
13. Novel Mutations in EPCAM Cause Congenital Tufting Enteropathy.
Tang W; Huang T; Xu Z; Huang Y
J Clin Gastroenterol; 2018 Jan; 52(1):e1-e6. PubMed ID: 27875355
[TBL] [Abstract][Full Text] [Related]
14. Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins.
Wu CJ; Lu M; Feng X; Nakato G; Udey MC
Cells; 2020 Apr; 9(4):. PubMed ID: 32326212
[TBL] [Abstract][Full Text] [Related]
15. SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase.
Holt-Danborg L; Vodopiutz J; Nonboe AW; De Laffolie J; Skovbjerg S; Wolters VM; Müller T; Hetzer B; Querfurt A; Zimmer KP; Jensen JK; Entenmann A; Heinz-Erian P; Vogel LK; Janecke AR
Hum Mol Genet; 2019 Mar; 28(5):828-841. PubMed ID: 30445423
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells.
Nakato G; Morimura S; Lu M; Feng X; Wu C; Udey MC
Cells; 2020 Aug; 9(8):. PubMed ID: 32781650
[TBL] [Abstract][Full Text] [Related]
17. Congenital Tufting Enteropathy-Associated Mutant of Epithelial Cell Adhesion Molecule Activates the Unfolded Protein Response in a Murine Model of the Disease.
Das B; Okamoto K; Rabalais J; Marchelletta RR; Barrett KE; Das S; Niwa M; Sivagnanam M
Cells; 2020 Apr; 9(4):. PubMed ID: 32290509
[TBL] [Abstract][Full Text] [Related]
18. A novel nonsense mutation in the EpCAM gene in a patient with congenital tufting enteropathy.
Thoeni C; Amir A; Guo C; Zhang S; Avitzur Y; Heng YM; Cutz E; Muise AM
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):18-21. PubMed ID: 24048167
[TBL] [Abstract][Full Text] [Related]
19. New mutations of
AlMahamed S; Hammo A
Saudi J Gastroenterol; 2017; 23(2):123-126. PubMed ID: 28361844
[TBL] [Abstract][Full Text] [Related]
20. Liver Pathology, Including MOC31 Immunohistochemistry, in Congenital Tufting Enteropathy.
Chen S; Goldsmith JD; Fawaz R; Al-Ibraheemi A; Perez-Atayde AR; Vargas SO
Am J Surg Pathol; 2021 Aug; 45(8):1091-1097. PubMed ID: 33756496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
